Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Alzheimer's Disease

  Free Subscription


15.04.2019

1 Alzheimer Dis Assoc Disord
1 Alzheimers Dement
1 Am J Alzheimers Dis Other Demen
1 Am J Psychiatry
1 BMJ
1 Brain Res
26 J Alzheimers Dis
1 J Neurochem
2 J Neurol
1 Lancet Neurol
2 N Engl J Med
1 Nat Rev Neurol
2 Neurobiol Aging
5 Neurology
1 Neuroreport
1 Neurosci Lett
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimer Dis Assoc Disord

  1. GRILL JD, Nuno MM, Gillen DL
    Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials?
    Alzheimer Dis Assoc Disord. 2019 Apr 4. doi: 10.1097/WAD.0000000000000303.
    PubMed     Text format     Abstract available


    Alzheimers Dement

  2. LLEO A, Alcolea D, Martinez-Lage P, Scheltens P, et al
    Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.
    Alzheimers Dement. 2019 Apr 6. pii: S1552-5260(19)30047.
    PubMed     Text format     Abstract available


    Am J Alzheimers Dis Other Demen

  3. TAKAHASHI M, Tada T, Nakamura T, Koyama K, et al
    Efficacy and Limitations of rCBF-SPECT in the Diagnosis of Alzheimer's Disease With Amyloid-PET.
    Am J Alzheimers Dis Other Demen. 2019 Apr 9:1533317519841192.
    PubMed     Text format     Abstract available


    Am J Psychiatry

  4. FARRELL M, Lichtenstein M, Crowley JJ, Filmyer DM, et al
    Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington's Disease.
    Am J Psychiatry. 2018;175:400-407.
    PubMed     Text format    


    BMJ

  5. MAKI PM, Girard LM, Manson JE
    Menopausal hormone therapy and cognition.
    BMJ. 2019;364:l877.
    PubMed     Text format    


    Brain Res

  6. MA XH, Duan WJ, Mo YS, Chen JL, et al
    Neuroprotective effect of paeoniflorin on okadaic acid-induced tau hyperphosphorylation via calpain/Akt/GSK-3beta pathway in SH-SY5Y cells.
    Brain Res. 2018;1690:1-11.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  7. BARDACH SH, Jicha GA, Karanth S, Zhang X, et al
    Genetic Sample Provision Among National Alzheimer's Coordinating Center Participants.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181159. doi: 10.3233/JAD-181159.
    PubMed     Text format     Abstract available

  8. GUO H, Zhao Z, Zhang R, Chen P, et al
    Monocytes in the Peripheral Clearance of Amyloid-beta and Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 3. pii: JAD181177. doi: 10.3233/JAD-181177.
    PubMed     Text format     Abstract available

  9. SHI X, Ohta Y, Liu X, Shang J, et al
    Acute Anti-Inflammatory Markers ITIH4 and AHSG in Mice Brain of a Novel Alzheimer's Disease Model.
    J Alzheimers Dis. 2019 Apr 3. pii: JAD181218. doi: 10.3233/JAD-181218.
    PubMed     Text format     Abstract available

  10. FARR SA, Roesler E, Niehoff ML, Roby DA, et al
    Metformin Improves Learning and Memory in the SAMP8 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 3. pii: JAD181240. doi: 10.3233/JAD-181240.
    PubMed     Text format     Abstract available

  11. ROE CM, Stout SH, Rajasekar G, Ances BM, et al
    A 2.5-Year Longitudinal Assessment of Naturalistic Driving in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 3. pii: JAD181242. doi: 10.3233/JAD-181242.
    PubMed     Text format     Abstract available

  12. SPENCER BE, Jennings RG, Brewer JB
    Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer's Disease Neuroimaging Initiative.
    J Alzheimers Dis. 2019 Apr 3. pii: JAD181243. doi: 10.3233/JAD-181243.
    PubMed     Text format     Abstract available

  13. REGALADO-REYES M, Furcila D, Hernandez F, Avila J, et al
    Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181263. doi: 10.3233/JAD-181263.
    PubMed     Text format     Abstract available

  14. LI C, Duara R, Loewenstein DA, Izquierdo W, et al
    Greater Regional Cortical Thickness is Associated with Selective Vulnerability to Atrophy in Alzheimer's Disease, Independent of Amyloid Load and APOE Genotype.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD180231. doi: 10.3233/JAD-180231.
    PubMed     Text format     Abstract available

  15. MARTINEZ JF, Trujillo C, Arevalo A, Ibanez A, et al
    Assessment of Conjunctive Binding in Aging: A Promising Approach for Alzheimer's Disease Detection.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181154. doi: 10.3233/JAD-181154.
    PubMed     Text format     Abstract available

  16. JERNEREN F, Cederholm T, Refsum H, Smith AD, et al
    Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181148. doi: 10.3233/JAD-181148.
    PubMed     Text format     Abstract available

  17. LI C, Li Y, Zheng L, Zhu X, et al
    Abnormal Brain Network Connectivity in a Triple-Network Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181097. doi: 10.3233/JAD-181097.
    PubMed     Text format     Abstract available

  18. GOETGHEBEUR PJD, Wesnes KA, Targum SD
    D-Cycloserine Improves Difficult Discriminations in a Pattern Separation Task in Alzheimer's Disease Patients with Dementia.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181094. doi: 10.3233/JAD-181094.
    PubMed     Text format     Abstract available

  19. YAN T, Wang Y, Weng Z, Du W, et al
    Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181049. doi: 10.3233/JAD-181049.
    PubMed     Text format     Abstract available

  20. MARIZZONI M, Ferrari C, Macis A, Jovicich J, et al
    Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181016. doi: 10.3233/JAD-181016.
    PubMed     Text format     Abstract available

  21. MUSTAPIC M, Tran J, Craft S, Kapogiannis D, et al
    Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD180578. doi: 10.3233/JAD-180578.
    PubMed     Text format     Abstract available

  22. PATRICK S, Corrigan R, Grizzani J, Mey M, et al
    Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer's Disease Are Associated with Oxidative Stress Regulation Mechanisms.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD180421. doi: 10.3233/JAD-180421.
    PubMed     Text format     Abstract available

  23. KUMAR S, Srivastav S, Fatima M, Giri RS, et al
    A Synthetic Pro-Drug Peptide Reverses Amyloid-beta-Induced Toxicity in the Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181273. doi: 10.3233/JAD-181273.
    PubMed     Text format     Abstract available

  24. QIU Q, Shen L, Jia L, Wang Q, et al
    A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Abeta42/Abeta40 ratio.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181291. doi: 10.3233/JAD-181291.
    PubMed     Text format     Abstract available

  25. CAO C, Hasegawa Y, Hayashi K, Takemoto Y, et al
    Chronic Angiotensin 1-7 Infusion Prevents Angiotensin-II-Induced Cognitive Dysfunction and Skeletal Muscle Injury in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181000. doi: 10.3233/JAD-181000.
    PubMed     Text format     Abstract available

  26. FRISONI GB, Blin O, Bordet R
    One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer's Disease Drugs: The Results of PharmaCog WP5 (European ADNI).
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190267. doi: 10.3233/JAD-190267.
    PubMed     Text format    

  27. MIAO Y, Guo D, Li W, Zhong Y, et al
    Diabetes Promotes Development of Alzheimer's Disease Through Suppression of Autophagy.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190156. doi: 10.3233/JAD-190156.
    PubMed     Text format     Abstract available

  28. PETUKHOVA EO, Mukhamedshina YO, Salafutdinov II, Garanina EE, et al
    Effects of Transplanted Umbilical Cord Blood Mononuclear Cells Overexpressing GDNF on Spatial Memory and Hippocampal Synaptic Proteins in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190150. doi: 10.3233/JAD-190150.
    PubMed     Text format     Abstract available

  29. COSTA AS, Guerini FR, Arosio B, Galimberti D, et al
    SNARE Complex Polymorphisms Associate with Alterations of Visual Selective Attention in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190147. doi: 10.3233/JAD-190147.
    PubMed     Text format     Abstract available

  30. LI WW, Shen YY, Tian DY, Bu XL, et al
    Brain Amyloid-beta Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190056. doi: 10.3233/JAD-190056.
    PubMed     Text format     Abstract available

  31. ROY U, Heredia-Munoz MT, Stute L, Hofling C, et al
    Degeneration of the Suprachiasmatic Nucleus in an Alzheimer's Disease Mouse Model Monitored by in vivo Magnetic Resonance Relaxation Measurements and Immunohistochemistry.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190037. doi: 10.3233/JAD-190037.
    PubMed     Text format     Abstract available

  32. PYUN JM, Kang MJ, Yun Y, Park YH, et al
    APOE varepsilon4 and REM Sleep Behavior Disorder as Risk Factors for Sundown Syndrome in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190032. doi: 10.3233/JAD-190032.
    PubMed     Text format     Abstract available


    J Neurochem

  33. MURAMATSU I, Uwada J, Yoshiki H, Sada K, et al
    Novel regulatory systems for acetylcholine release in rat striatum and anti-Alzheimer's disease drugs.
    J Neurochem. 2019 Apr 10. doi: 10.1111/jnc.14701.
    PubMed     Text format     Abstract available


    J Neurol

  34. MANCA C, Rivasseau Jonveaux T, Roch V, Marie PY, et al
    Amyloid PETs are commonly negative in suspected Alzheimer's disease with an increase in CSF phosphorylated-tau protein concentration but an Abeta42 concentration in the very high range: a prospective study.
    J Neurol. 2019 Apr 8. pii: 10.1007/s00415-019-09315.
    PubMed     Text format     Abstract available

  35. OKUDA S, Tetsuka J, Takahashi K, Toda Y, et al
    Association between sleep disturbance in Alzheimer's disease patients and burden on and health status of their caregivers.
    J Neurol. 2019 Apr 9. pii: 10.1007/s00415-019-09286.
    PubMed     Text format     Abstract available


    Lancet Neurol


  36. Jo Barnes.
    Lancet Neurol. 2018;17:667.
    PubMed     Text format    


    N Engl J Med

  37. EGAN MF, Kost J, Voss T, Mukai Y, et al
    Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease.
    N Engl J Med. 2019;380:1408-1420.
    PubMed     Text format    

  38. HENLEY D, Raghavan N, Sperling R, Aisen P, et al
    Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease.
    N Engl J Med. 2019;380:1483-1485.
    PubMed     Text format    


    Nat Rev Neurol

  39. LEMPRIERE S
    Birth of hippocampal neurons declines in Alzheimer disease.
    Nat Rev Neurol. 2019 Apr 5. pii: 10.1038/s41582-019-0182.
    PubMed     Text format    


    Neurobiol Aging

  40. WEINER MW, Toga A, Harvey D, Donohue M, et al
    Response to Zywieck and Kirkby paper.
    Neurobiol Aging. 2018;69:298-299.
    PubMed     Text format    

  41. WRIGHT SM, Jensen SL, Cockriel KL, Davis B, et al
    Association study of rs3846662 with Alzheimer's disease in a population-based cohort: the Cache County Study.
    Neurobiol Aging. 2019 Mar 15. pii: S0197-4580(19)30082.
    PubMed     Text format     Abstract available


    Neurology

  42. MEYER PF, Tremblay-Mercier J, Leoutsakos J, Madjar C, et al
    INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.
    Neurology. 2019 Apr 5. pii: WNL.0000000000007232.
    PubMed     Text format     Abstract available

  43. LATTANZI S, Silvestrini M
    Reader response: Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology.
    Neurology. 2019;92:731.
    PubMed     Text format    

  44. ARVANITAKIS Z, Capuano AW
    Author response: Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology.
    Neurology. 2019;92:732.
    PubMed     Text format    

  45. HERSHEY LA, Lipton RB
    Naproxen for presymptomatic Alzheimer disease: Is this the end, or shall we try again?
    Neurology. 2019 Apr 5. pii: WNL.0000000000007233.
    PubMed     Text format    

  46. SIEGLER JE 3RD, Galetta S
    Editors' note: Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology.
    Neurology. 2019;92:731.
    PubMed     Text format    


    Neuroreport

  47. SHANG YY, Ma YJ, Zhang L, Wang LJ, et al
    Flavonoids extracted from leaves of Diospyros kaki regulates RhoA activity to rescue synapse loss and reverse memory impairment in APP/PS1 mice.
    Neuroreport. 2018;29:564-569.
    PubMed     Text format     Abstract available


    Neurosci Lett

  48. SHOZAWA H, Oguchi T, Tsuji M, Yano S, et al
    Supratherapeutic concentrations of cilostazol inhibits beta-amyloid oligomerization in vitro.
    Neurosci Lett. 2018;677:19-25.
    PubMed     Text format     Abstract available


    PLoS One

  49. KIM JE, Park JJ, Lee MR, Choi JY, et al
    Constipation in Tg2576 mice model for Alzheimer's disease associated with dysregulation of mechanism involving the mAChR signaling pathway and ER stress response.
    PLoS One. 2019;14:e0215205.
    PubMed     Text format     Abstract available

  50. ROBY DA, Ruiz F, Kermath BA, Voorhees JR, et al
    Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-beta burden in a mouse model of Alzheimer's disease.
    PLoS One. 2019;14:e0215004.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: